DJ Eli Lilly & Co. Stock Underperforms Friday When Compared To Competitors
This article was automatically generated by MarketWatch using technology from Automated Insights.
Shares of Eli Lilly & Co. $(LLY)$ slid 3.00% to $844.27 Friday, on what proved to be an all-around grim trading session for the stock market, with the S&P 500 Index falling 0.01% to 6,114.63 and Dow Jones Industrial Average falling 0.37% to 44,546.08.
This was the stock's second consecutive day of losses.
Eli Lilly & Co. closed 13.19% below its 52-week high of $972.53, which the company achieved on August 22nd.
The stock underperformed when compared to some of its competitors Friday, as Johnson & Johnson $(JNJ)$ fell 0.70% to $156.15, Pfizer Inc. $(PFE)$ fell 0.43% to $25.53, and AbbVie Inc. $(ABBV)$ fell 0.30% to $192.87.
Trading volume (3.2 M) remained 358,712 below its 50-day average volume of 3.6 M.
Data source: Dow Jones Market Data, FactSet. Data compiled February 14, 2025.
This content was created by MarketWatch, which is operated by Dow Jones & Co. MarketWatch is published independently from Dow Jones Newswires and The Wall Street Journal.
(END) Dow Jones Newswires
February 14, 2025 16:32 ET (21:32 GMT)
Copyright (c) 2025 Dow Jones & Company, Inc.
免责声明:投资有风险,本文并非投资建议,以上内容不应被视为任何金融产品的购买或出售要约、建议或邀请,作者或其他用户的任何相关讨论、评论或帖子也不应被视为此类内容。本文仅供一般参考,不考虑您的个人投资目标、财务状况或需求。TTM对信息的准确性和完整性不承担任何责任或保证,投资者应自行研究并在投资前寻求专业建议。